Anuja Herbaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 16-12-2024
- Paid Up Capital ₹ 3.00 M
as on 16-12-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.08 M
as on 16-12-2024
- Revenue 139.38%
(FY 2022)
- Profit 105.77%
(FY 2022)
- Ebitda -68.52%
(FY 2022)
- Net Worth 35.92%
(FY 2022)
- Total Assets 37.96%
(FY 2022)
About Anuja Herbaceuticals
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹7.08 M.
Amal Barui, Dinesh Bhura, and Biplab Pattanayak serve as directors at the Company.
- CIN/LLPIN
U24304WB2016PTC215921
- Company No.
215921
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Anuja Herbaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amal Barui  | Director | 25-May-2016 | Current |
| Dinesh Bhura | Additional Director | 14-Nov-2022 | Current |
| Biplab Pattanayak | Additional Director | 25-Jan-2019 | Current |
Financial Performance and Corporate Structure Insights of Anuja Herbaceuticals.
Anuja Herbaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 139.38% increase. The company also saw a substantial improvement in profitability, with a 105.77% increase in profit. The company's net worth Soared by an impressive increase of 35.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anuja Herbaceuticals?
In 2020, Anuja Herbaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Centella Healthcare Private LimitedActive 11 years 3 monthsAmal Barui and Biplab Pattanayak are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 19 Nov 2024 | ₹1.50 M | Open |
Hdfc Bank Limited Creation Date: 27 Jul 2023 | ₹0.48 M | Open |
State Bank Of India Creation Date: 23 May 2019 | ₹5.10 M | Open |
How Many Employees Work at Anuja Herbaceuticals?
Anuja Herbaceuticals has a workforce of 16 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anuja Herbaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anuja Herbaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
